文献速递骨显像与常规 SPECT

三分钟SPECT/CT足以作为平面骨显像附加检查评估骨转移:与11分钟SPECT/CT的前瞻性头对头比较

Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT.
PubMed 文献 · EJNMMI Res · 2017-01-05

本研究纳入104例转诊行全身骨显像的癌症患者,前瞻性比较超快速SPECT/CT(3分钟)与标准SPECT/CT(11分钟)作为附加检查评估骨转移的诊断一致性。结果显示两种方案在三分类评估中一致性极好(kappa=0.91,95%CI 0.84-0.97),超快速SPECT/CT可在不损害诊断信心的前提下显著缩短采集时间。

要点

  • 超快速SPECT/CT(3分钟)与标准SPECT/CT(11分钟)在骨转移三分类评估中一致性极好,kappa=0.91(95%CI 0.84-0.97)。
  • 在全身骨显像不能完全诊断的104例中,SPECT/CT为90例提供了确定性分类。
  • 不同癌种间观察者一致性无差异。

核心结论

  • 为评估潜在骨转移,超快速SPECT/CT可作为全身骨显像的附加检查,在显著缩短SPECT采集时间的同时不损害诊断信心。

研究设计与样本

  • 前瞻性头对头比较研究,连续纳入转诊行全身骨显像并附加SPECT/CT的癌症患者104例。
  • 标准SPECT参数为矩阵128×128、放大因子1、20秒/帧、32帧;超快速SPECT除10秒/帧和16帧外参数相同,采集时间从11分钟缩短至3分钟。
  • 两名观察者对每组图像(全身骨显像+标准SPECT/CT或全身骨显像+超快速SPECT/CT)达成共识诊断,采用三分类评估量表:M0无骨转移、M1骨转移、Me不确定。

主要发现

  • 104例患者中,前列腺癌71例、乳腺癌28例。
  • 使用全身骨显像+标准SPECT/CT,71例(68%)分类为M0,19例(18%)为M1,14例(14%)为Me。
  • 全身骨显像+标准SPECT/CT与全身骨显像+超快速SPECT/CT在三分类量表间一致性极好:kappa=0.91(95%CI 0.84-0.97)。
  • 不同癌种间未检测到观察者一致性差异。
  • 在全身骨显像不能完全诊断的104例中,SPECT/CT为90例提供了确定性分类。

临床怎么用

  • 原文结论认为,为评估潜在骨转移,超快速SPECT/CT可作为全身骨显像的附加检查,在显著缩短SPECT采集时间的同时不损害诊断信心。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study is to assess whether ultra-fast acquisition SPECT/CT (UF-SPECT/CT) can replace standard SPECT/CT (std-SPECT/CT) as "add-on" to whole-body bone scintigraphy (WB-BS) for the investigation of bone metastases. Consecutive cancer patients referred for WB-BS who underwent SPECT/CT in addition to WB-BS were included. Std-SPECT, UF-SPECT, and low-dose CT were performed (std-SPECT: matrix 128 × 128, zoom factor 1, 20 s/view, 32 views; UF-SPECT: identical parameters except for 10 s/view and 16 views, reducing the acquisition time from 11 to 3 min). A consensus diagnosis was reached by two observers for each set of images (WB-BS + standard SPECT/CT or WB-BS + UF-SPECT/CT) using a three-category evaluation scale: M0: no bone metastases; M1: bone metastases; and Me: equivocal findings. RESULTS: Among the 104 included patients, most presented with prostate cancer (n = 71) or breast cancer (n = 28). Using WB-BS + std-SPECT/CT, 71 (68%) patients were classified as M0, 19 (18%) as M1, and 14 (14%) as Me. Excellent agreement was observed between WB-BS + std-SPECT/CT and WB-BS + UF-SPECT/CT using the three-category scale: kappa = 0.91 (95% CI 0.84-0.97). No difference in observer agreement between cancer types was detected. SPECT/CT provided a definitive classification in 90 of 104 cases in which WB-BS was not entirely diagnostic. CONCLUSIONS: To investigate potential bone metastases, UF-SPECT/CT can be conducted as add-on to WB-BS to notably reduce the SPECT acquisition time without compromising diagnostic confidence.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Zacho HD, Manresa JAB, Aleksyniene R, et al. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT. EJNMMI Res. 2017. PMID: 28058659. doi:10.1186/s13550-016-0252-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。